A Phase I Trial of Ipilimumab (IPI) in Patients (PTS) with Myelodysplastic Syndromes (MDS) after Hypomethylating Agent (HMAS) Failure. (April 2017)

Record Type:
Journal Article
Title:
A Phase I Trial of Ipilimumab (IPI) in Patients (PTS) with Myelodysplastic Syndromes (MDS) after Hypomethylating Agent (HMAS) Failure. (April 2017)
Main Title:
A Phase I Trial of Ipilimumab (IPI) in Patients (PTS) with Myelodysplastic Syndromes (MDS) after Hypomethylating Agent (HMAS) Failure
Authors:
Zeidan, A.
Knaus, H.
Robinson, T.
Zeidner, J.
Blackford, A.
Duffield, A.
Rizzieri, D.
Frattini, M.
Levy, M.Y.
Schroeder, M.
Ferguson, A.
Sheldon, K.
Dezern, A.
Gojo, I.
Gore, S.
Streicher, H.
Luznik, L.
Smith, B.D.
Abstract:
Is Part Of:
Leukemia research. Volume 55(2017)Supplement 1
Journal:
Leukemia research
Issue:
Volume 55(2017)Supplement 1
Issue Display:
Volume 55, Issue 1 (2017)
Year:
2017
Volume:
55
Issue:
1
Issue Sort Value:
2017-0055-0001-0000
Page Start:
S43
Page End:
Publication Date:
2017-04
Subjects:
Leukemia -- Periodicals
Leukemia -- Periodicals
Leucémie -- Périodiques
Leukemia
Periodicals
Electronic journals
Electronic journals
616.9941905
Journal URLs:
http://www.sciencedirect.com/science/journal/01452126 ↗
http://www.elsevier.com/journals ↗
DOI:
10.1016/S0145-2126(17)30177-7 ↗
Languages:
English
ISSNs:
0145-2126
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 5185.270000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
439.xml